Race and Ethnicity Differences in Disease Severity and Visual Field Progression Among Glaucoma Patients.


Journal

American journal of ophthalmology
ISSN: 1879-1891
Titre abrégé: Am J Ophthalmol
Pays: United States
ID NLM: 0370500

Informations de publication

Date de publication:
10 2022
Historique:
received: 07 12 2021
revised: 23 05 2022
accepted: 25 05 2022
pubmed: 3 6 2022
medline: 28 9 2022
entrez: 2 6 2022
Statut: ppublish

Résumé

Investigate associations of race/ethnicity and preferred language with baseline glaucoma severity, VF test frequency and disease progression. Retrospective cohort study. Patients receiving VF testing at a tertiary eyecare center between 1998 and 2020 with self-identified race, ethnicity and preferred language were included. Outcome measures were VF MD and age at first visit, VF test frequency, VF MD progression. Among 29,891 patients with VF measurements between 1998 and 2020, 55.1% were female, 71.0% self-identified as White/Caucasian, 14.0% as Black/African American, 7.4% as Asian and 6.4% as Hispanic, and 11.2% preferred a language other than English. Mean VF MD at presentation was worse among Black (-9.3±9.7 dB), Asian (-6.2±7.6 dB) and Hispanic (-8.3±9.3 dB) patients (vs. Whites [-5.5±7.3 dB, p<0.001] or non-Hispanics [-6.2±7.8 dB, p<0.001]). After controlling for age, gender and English proficiency, disparities in glaucoma severity at presentation were reduced, especially among Asian and Hispanic patients. Despite greater severity at presentation, Black patients had lower VF test frequency/person-years (1.07±0.53) compared to Whites (1.12±0.52, p=0.006) and worse VF MD progression (-0.43 dB/year, 95% CI -0.67 to -0.28, p<0.001). In contrast, Hispanics had a higher VF frequency vs. non-Hispanics (1.18±0.64 vs. 1.11±0.52, p<0.001), and no difference in VF progression (p=0.77). Black, Asian and Hispanic patients had greater baseline severity vs. Whites. Unlike other groups, Black patients had a lower VF frequency vs. Whites and greater VF progression. Disparities in baseline severity were partially explained by English proficiency, especially for Asian and Hispanic patients.

Identifiants

pubmed: 35654121
pii: S0002-9394(22)00223-9
doi: 10.1016/j.ajo.2022.05.023
pmc: PMC9842097
mid: NIHMS1860844
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

69-76

Subventions

Organisme : NEI NIH HHS
ID : R01 EY030575
Pays : United States
Organisme : NEI NIH HHS
ID : R00 EY028631
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY015473
Pays : United States
Organisme : NEI NIH HHS
ID : P30 EY003790
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY032559
Pays : United States
Organisme : NEI NIH HHS
ID : K23 EY032634
Pays : United States

Informations de copyright

Copyright © 2022 Elsevier Inc. All rights reserved.

Références

Acad Emerg Med. 2017 Aug;24(8):895-904
pubmed: 28472533
Br J Ophthalmol. 2010 Jan;94(1):85-7
pubmed: 19628488
Can J Ophthalmol. 2009 Feb;44(1):66-9
pubmed: 19169316
Ophthalmology. 2011 Jun;118(6):1031-7
pubmed: 21310489
Int J Health Policy Manag. 2017 Aug 05;7(1):1-9
pubmed: 29325397
Ophthalmology. 2005 Mar;112(3):401-6
pubmed: 15745765
Eye (Lond). 2015 Oct;29(10):1360-7
pubmed: 26315700
Hum Mol Genet. 2017 Aug 1;26(R1):R21-R27
pubmed: 28505344
Arch Ophthalmol. 2005 Dec;123(12):1693-8
pubmed: 16344441
JAMA Intern Med. 2019 Apr 1;179(4):469-476
pubmed: 30742196
Am J Epidemiol. 1993 Sep 15;138(6):395-406
pubmed: 8213745
Eye (Lond). 2009 May;23(5):1038-44
pubmed: 18688262
JAMA. 1991 Jul 17;266(3):369-74
pubmed: 2056646
JAMA Netw Open. 2019 Nov 1;2(11):e1916018
pubmed: 31755951
Am Fam Physician. 2016 Apr 15;93(8):668-74
pubmed: 27175839
Arch Ophthalmol. 2000 Feb;118(2):253-6
pubmed: 10676791
Can J Ophthalmol. 2013 Apr;48(2):83-7
pubmed: 23561599
Ophthalmic Epidemiol. 1997 Jun;4(2):89-100
pubmed: 9243653
J Glaucoma. 2014 Jun-Jul;23(5):293-8
pubmed: 23377584
Ethn Health. 2009 Dec;14(6):625-42
pubmed: 19953393
BMJ. 2001 Mar 17;322(7287):639-43
pubmed: 11250847
N Engl J Med. 1991 Nov 14;325(20):1418-22
pubmed: 1922253
J Immigr Minor Health. 2019 Apr;21(2):264-270
pubmed: 29797103
BMC Health Serv Res. 2021 Jul 26;21(1):741
pubmed: 34311712
J Am Optom Assoc. 1989 Oct;60(10):760-7
pubmed: 2685083
Am J Ophthalmol. 2005 Oct;140(4):598-606
pubmed: 16226511
J Gen Intern Med. 2007 Sep;22(9):1231-8
pubmed: 17594129
Ophthalmology. 2004 Aug;111(8):1439-48
pubmed: 15288969
JAMA Ophthalmol. 2014 Jul;132(7):838-44
pubmed: 24830878
Ophthalmology. 2022 Apr;129(4):397-405
pubmed: 34626697
Optom Vis Sci. 2013 Aug;90(8):883-97
pubmed: 23873033

Auteurs

Omar A Halawa (OA)

From the Department of Ophthalmology, Massachusetts Eye and Ear/Mass General Brigham, Harvard Medical School, Boston, MA, USA (O.A.H, A.C.L, L.S, J.W.M, N.Z).

Qingying Jin (Q)

Department of Psychology, School of Philosophy and Sociology, Jilin University, Changchun, Jilin, China (Q.J); Schepens Eye Research Institute of Mass Eye and Ear, Harvard Medical School, Boston, MA, USA (Q.J, Y.L, M.E, M.W, T.E).

Louis R Pasquale (LR)

Department of Ophthalmology, Icahn School of Medicine at Mount Sinai, New York, NY, USA (L.R.P).

Jae H Kang (JH)

Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA (J.H.K).

Alice C Lorch (AC)

From the Department of Ophthalmology, Massachusetts Eye and Ear/Mass General Brigham, Harvard Medical School, Boston, MA, USA (O.A.H, A.C.L, L.S, J.W.M, N.Z).

Lucia Sobrin (L)

From the Department of Ophthalmology, Massachusetts Eye and Ear/Mass General Brigham, Harvard Medical School, Boston, MA, USA (O.A.H, A.C.L, L.S, J.W.M, N.Z).

Joan W Miller (JW)

From the Department of Ophthalmology, Massachusetts Eye and Ear/Mass General Brigham, Harvard Medical School, Boston, MA, USA (O.A.H, A.C.L, L.S, J.W.M, N.Z).

Yangjiani Li (Y)

Schepens Eye Research Institute of Mass Eye and Ear, Harvard Medical School, Boston, MA, USA (Q.J, Y.L, M.E, M.W, T.E).

Mohammad Eslami (M)

Schepens Eye Research Institute of Mass Eye and Ear, Harvard Medical School, Boston, MA, USA (Q.J, Y.L, M.E, M.W, T.E).

Mengyu Wang (M)

Schepens Eye Research Institute of Mass Eye and Ear, Harvard Medical School, Boston, MA, USA (Q.J, Y.L, M.E, M.W, T.E).

Nazlee Zebardast (N)

From the Department of Ophthalmology, Massachusetts Eye and Ear/Mass General Brigham, Harvard Medical School, Boston, MA, USA (O.A.H, A.C.L, L.S, J.W.M, N.Z).

Tobias Elze (T)

Schepens Eye Research Institute of Mass Eye and Ear, Harvard Medical School, Boston, MA, USA (Q.J, Y.L, M.E, M.W, T.E). Electronic address: tobias_elze@meei.harvard.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH